Christoph Huber

Ganymed Pharmaceuticals AG develops antibodies for the treatment of solid cancers. It focuses on developing ideal monoclonal antibodies that include cancer-selective targets for maximal high-precision anticancer potency, as well as mitigates the threat of toxicity. The company was founded by Özlem Türeci, Dirk L. Sebastian, Christoph Huber and Ugur Sahin in 2001 and is headquartered in Mainz, Germany.

AFFiRiS AG develops and produces vaccines for therapeutic treatment of chronic diseases. It provides research services and develops vaccines based on peptide antigens applied in the fields of biochemistry, molecular and cell biology, immunology and veterinary medicine. AFFiRiS was founded by Walter Schmidt and Frank Mattner in November 2003 and is headquartered in Vienna, Austria.

TRON - Translationale Onkologie an der Universitätsmedizin der is an independent biopharmaceutical non-profit translational research organization located in Mainz, Germany. TRON pursues new diagnostics and drugs for the treatment of cancer and other diseases with high medical need through their PhD Program. The German company was founded in 2010 by Ugur Sahin and the CEO is Michael Föhlings.

Tonestro is a music app that provides wind instrument lessons for individuals to learn and practice at home. The company is based in Pierbach, Austria. The app offers live feedback on rhythm and pitch while listening to the user play their instrument. The Austrian company was founded by Alexander Kogler, Christian Kapplmüller, Heinrich Huber, Christoph Huber, with Christoph Huber serving as CEO since its inception.

Onsight Ventures Management GmbH (Onsight Ventures) is a venture capital firm founded in 2021. The firm is headquartered in Innsbruck, Austria.